Patent details

EP3097915 Title: IMPROVED SUSPENSION FORMULATION OF A CORTICOSTEROID FOR ADMINISTRATION BY INHALATION

Basic Information

Publication number:
EP3097915
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161786249
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMPROVED SUSPENSION FORMULATION OF A CORTICOSTEROID FOR ADMINISTRATION BY INHALATION
French Title of Invention:
FORMULATION DE SUSPENSION AMÉLIORÉE D'UN CORTICOSTÉROÏDE POUR ADMINISTRATION PAR INHALATION
German Title of Invention:
VERBESSERTE SUSPENSIONSFORMULIERUNG EINES CORTICOSTEROIDS ZUR VERABREICHUNG MITTELS INHALATION
SPC Number:

Dates

Filing date:
18/04/2012
Grant date:
24/01/2024
EP Publication Date:
30/11/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/01/2024
EP B1 Publication Date:
24/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/04/2024
Expiration date:
18/04/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/01/2024
 
 

Name:
Chiesi Farmaceutici S.p.A.
Address:
Via Palermo, 26/A, 43122 Parma, Italy (IT)

Inventor

1

Name:
BASSI, Barbara
Address:
Italy (IT)

2

Name:
CANTARELLI, Anna Maria
Address:
Italy (IT)

3

Name:
MINARI, Stefano
Address:
Italy (IT)

Priority

Priority Number:
11164575
Priority Date:
03/05/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 45/06; A61K 31/137; A61P 11/00; A61K 31/573; A61K 9/00; A61P 11/08;

Publication

European Patent Bulletin

Issue number:
202404
Publication date:
24/01/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages